ANDRINI, ELISA

ANDRINI, ELISA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Assegnisti  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.081 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
An Update on Appendiceal Neuroendocrine Tumors Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D. 2023-01-01 CURRENT TREATMENT OPTIONS IN ONCOLOGY - 1.01 Articolo in rivista Andrini_2023.pdf
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; ...Lamberti G. 2023-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Mar...ia Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA 2023-01-01 JOURNAL OF CLINICAL MEDICINE - 1.01 Articolo in rivista jcm-12-00717.pdf
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm Lamberti, Giuseppe; Andrini, Elisa; Ricci, Claudio; Campana, Davide 2023-01-01 THE LANCET ONCOLOGY - 1.01 Articolo in rivista -
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. 2023-01-01 JOURNAL OF NEUROLOGY - 1.01 Articolo in rivista Rossi_JN_2023.pdf
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; An...drea Lisotti; Davide Campana 2023-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista curroncol-30-00106-v2.pdf
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) Lamberti G.; Prinzi N.; Bongiovanni A.; Torniai M.; Andrini E.; Biase D.D.; Malvi D.; Mosca M.; B...erardi R.; Ibrahim T.; Pusceddu S.; Campana D. 2023-01-01 DIAGNOSTICS - 1.01 Articolo in rivista diagnostics-13-01595-v3.pdfdiagnostics-13-01595-s001.zip
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer Ricciuti B.; Mira A.; Andrini E.; Scaparone P.; Michelina S.V.; Pecci F.; Cantini L.; De Giglio A....; Lamberti G.; Ambrogio C.; Metro G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelso...mino F. 2022-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D....; Lamberti G. 2022-01-01 JOURNAL OF CLINICAL MEDICINE - 1.01 Articolo in rivista jcm-11-01461.pdf
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; C...asadei R.; Campana D. 2022-01-01 CANCER MEDICINE - 1.01 Articolo in rivista Lamberti_Cancer Medicine_2022.pdfDownloads.zip
Non-small-cell lung cancer: how to manage RET-positive disease Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations Cortellini A.; Ricciuti B.; Vaz V.R.; Soldato D.; Alessi J.V.; Dall'olio F.G.; Banna G.L.; Muthur...amalingam S.; Chan S.; Majem M.; Piedra A.; Lamberti G.; Andrini E.; Addeo A.; Friedlaender A.; Facchinetti F.; Gorria T.; Mezquita L.; Hoton D.; Valerie L.; Nana F.A.; Artingstall J.; Comins C.; Di Maio M.; Caglio A.; Cave J.; McKenzie H.; Newsom-Davis T.; Evans J.S.; Tiseo M.; D'Alessio A.; Fulgenzi C.A.M.; Besse B.; Awad M.M.; Pinato D.J. 2022-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista Cortellini et al, Journal for ImmunoTherapy of Cancer 2022.pdfjitc-2021-004374supp001_data_supplement.pdf
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis Mollica V.; Massari F.; Andrini E.; Rosellini M.; Marchetti A.; Nuvola G.; Tassinari E.; Lamberti... G.; Campana D. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista Vescica_SEER.pdfcurroncol-29-00461-s001.zip
Antibody–drug conjugates for lung cancer in the era of personalized oncology Ricciuti B.; Lamberti G.; Andrini E.; Genova C.; De Giglio A.; Bianconi V.; Sahebkar A.; Chiari R....; Pirro M. 2021-01-01 SEMINARS IN CANCER BIOLOGY - 1.01 Articolo in rivista -
Bone targeting agents in patients with metastatic prostate cancer: State of the art Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucc...i C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F. 2021-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2021 [Bone Mets].pdf
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? Ricco G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Casadei R.; Campana D.; Lambe...rti G. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-10629-v2.pdf